Cargando…

Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis

BACKGROUND AND OBJECTIVES: Adapted ketogenic diet (AKD) and caloric restriction (CR) have been suggested as alternative therapeutic strategies for multiple sclerosis (MS), but information on their impact on neuroaxonal damage is lacking. Thus, we explored the impact of diets on serum neurofilament l...

Descripción completa

Detalles Bibliográficos
Autores principales: Bock, Markus, Steffen, Falk, Zipp, Frauke, Bittner, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587737/
https://www.ncbi.nlm.nih.gov/pubmed/34764215
http://dx.doi.org/10.1212/NXI.0000000000001102
_version_ 1784598233957269504
author Bock, Markus
Steffen, Falk
Zipp, Frauke
Bittner, Stefan
author_facet Bock, Markus
Steffen, Falk
Zipp, Frauke
Bittner, Stefan
author_sort Bock, Markus
collection PubMed
description BACKGROUND AND OBJECTIVES: Adapted ketogenic diet (AKD) and caloric restriction (CR) have been suggested as alternative therapeutic strategies for multiple sclerosis (MS), but information on their impact on neuroaxonal damage is lacking. Thus, we explored the impact of diets on serum neurofilament light chain (sNfL) levels in patients with relapsing-remitting MS. METHODS: We retrospectively evaluated a prospective randomized controlled trial of 60 patients with MS who were on a common diet or ketogenic diet or fasting. We examined sNfL levels of 40 participants at baseline and at the end of the study after 6 months using single molecule array assay. RESULTS: sNfL levels were investigated in 9 controls, 14 participants on CR, and 17 participants on AKD. Correlation analysis showed an association of sNfL with age and disease duration; an association was also found between sNfL and the Multiple Sclerosis Functional Composite. AKD significantly reduced sNfL levels at 6 months compared with the common diet group (p = 0.001). DISCUSSION: For clinical or study use, consider that AKD may incline sNfL levels independent of relapse activity up to 3 months after initiation. At 6 months, AKD, which complements current therapies, reduced sNfL levels, therefore suggesting potential neuroprotective effects in MS. A single cycle of seven-day fasting did not affect sNfL. AKD may be an addition to the armamentarium to help clinicians support patients with MS in a personalized manner with tailored diet strategies.
format Online
Article
Text
id pubmed-8587737
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-85877372021-11-12 Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis Bock, Markus Steffen, Falk Zipp, Frauke Bittner, Stefan Neurol Neuroimmunol Neuroinflamm Article BACKGROUND AND OBJECTIVES: Adapted ketogenic diet (AKD) and caloric restriction (CR) have been suggested as alternative therapeutic strategies for multiple sclerosis (MS), but information on their impact on neuroaxonal damage is lacking. Thus, we explored the impact of diets on serum neurofilament light chain (sNfL) levels in patients with relapsing-remitting MS. METHODS: We retrospectively evaluated a prospective randomized controlled trial of 60 patients with MS who were on a common diet or ketogenic diet or fasting. We examined sNfL levels of 40 participants at baseline and at the end of the study after 6 months using single molecule array assay. RESULTS: sNfL levels were investigated in 9 controls, 14 participants on CR, and 17 participants on AKD. Correlation analysis showed an association of sNfL with age and disease duration; an association was also found between sNfL and the Multiple Sclerosis Functional Composite. AKD significantly reduced sNfL levels at 6 months compared with the common diet group (p = 0.001). DISCUSSION: For clinical or study use, consider that AKD may incline sNfL levels independent of relapse activity up to 3 months after initiation. At 6 months, AKD, which complements current therapies, reduced sNfL levels, therefore suggesting potential neuroprotective effects in MS. A single cycle of seven-day fasting did not affect sNfL. AKD may be an addition to the armamentarium to help clinicians support patients with MS in a personalized manner with tailored diet strategies. Lippincott Williams & Wilkins 2021-11-11 /pmc/articles/PMC8587737/ /pubmed/34764215 http://dx.doi.org/10.1212/NXI.0000000000001102 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Article
Bock, Markus
Steffen, Falk
Zipp, Frauke
Bittner, Stefan
Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis
title Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis
title_full Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis
title_fullStr Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis
title_full_unstemmed Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis
title_short Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis
title_sort impact of dietary intervention on serum neurofilament light chain in multiple sclerosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587737/
https://www.ncbi.nlm.nih.gov/pubmed/34764215
http://dx.doi.org/10.1212/NXI.0000000000001102
work_keys_str_mv AT bockmarkus impactofdietaryinterventiononserumneurofilamentlightchaininmultiplesclerosis
AT steffenfalk impactofdietaryinterventiononserumneurofilamentlightchaininmultiplesclerosis
AT zippfrauke impactofdietaryinterventiononserumneurofilamentlightchaininmultiplesclerosis
AT bittnerstefan impactofdietaryinterventiononserumneurofilamentlightchaininmultiplesclerosis